Search
01/01/2026
Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans
Galbiati, F, Plessow, F, Plummer, L, Campbell, MB, Nazarloo, S, Carter, CS, Davis, JM, Miller, KK, Carroll, RS, Kaiser, UB, Seminara, SB, Aulinas, A, Lawson, EA. Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans. JOURNAL OF NEUROENDOCRINOLOGY. 2026; 38(1)DOI:10.1111/jne.70114. PMID:41273106. IF:4.100(Q1/3D).
01/01/2026
Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males
Teller, M, Giordano, A, González-Munoza, C, Gordillo, J, Bertoletti, F, Sánchez-Reus, F, Garcia-Planella, E. Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males. Gastroenterologia y Hepatologia. 2026; 49(1)DOI:10.1016/j.gastrohep.2025.502558. PMID:40930415. IF:1.900(Q3/7D).
01/01/2026
Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU
Ramos, CR, Sard, MC, Carballo-Folgoso, L, Ruiz-Rodríguez, J, Moya, MIC, Teller, M, Clotet, AF, Cortés, IL, San Martín, LZ, Moreno, CO, Rivas, C, Cuellar, MA, Elorza, A, Gisbert, J, Martinez, MR, Poceiro, JC, Brunet, E, Caravaca, C, Rey, IB, Piñero, GS, Diaz, AP, Orenga, C, Carrilloramos, MJ, Montero, MG, Sandoval, CT, Velázquez, LM, Olmedo-Martín, R, Catalá, AC, Alonso,, Molina, IGDL, Molina, F, Salmón, P, Giordano, A, Moranta, FR, Zabana, Y, Planella, EG. Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1197. PMID:. IF:8.700(Q1/1D).
01/01/2026
Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU
Casanova, MJ, Garcia, RMD, Ramos, CL, Camba, AH, Gargayo-Puyuelo, C, Senosiain, BC, Gismero, FM, Pagola, L, Cruañas, AA, Giordano, A, Diaz, AP, Velázquez, LM, Robledo-Andrés, P, Regueiro, C, Gonzalez, MS, Jara, RA, Santos, DC, Glaría, EB, Marquès-Camí, M, Trastoy, PV, Acosta, MBD, de la Osa, DR, Luque, RS, Teller, M, De Célix, CR, Almela, P, Font-Ordeig, G, Bujanda, L, Orenga-Sánchez, C, Oliveras-Font, B, Alvarez, PGI, Sánchez, RM, Guillena, PGD, Arce, NM, Martinez, IP, Alonso, FJG, Ramos, CR, Moral, ED, Chaparro, M, Gisbert, J. Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.960. PMID:. IF:8.700(Q1/1D).
01/01/2026
Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA
De Célix, CR, Granja, A, Iborra, M, Alonso, FJG, Vela, M, de Castro, L, García-Sola, C, Barrero, S, Trastoy, PV, Andrés, PR, Riestra, S, Diaz, AP, Santos, DC, Camps, B, Gisbert, J, García, MJ, Palomares, MTDL, Lozano, OM, de la Cruz, DR, López, E, Pascual, CM, Izquierdo, S, Flores, EI, Iglesias, RF, Argüelles-Arias, F, Martin, D, Ramírez, MAR, Villaamil, PV, Martinez, AMT, Ramos, CR, Velázquez, LM, Ciria, MM, Brunet, E, Zabana, Y, Villarroya, RP, Altadill, A, Moral, ED, Mateu, PN, Acosta, MBD, San Jose, FB. Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.069. PMID:. IF:8.700(Q1/1D).
01/01/2026
Safety of biologic and small molecule therapies in IBD patients with previous cancer: risk of recurrence or new neoplasia
Calvo, M, Fernández-Felix, BM, Jiménez, IO, Guardia, JL, Menéndez, SR, Gismero, FM, Parga, MLD, Trastoy, PV, Vela, M, Carrasco, NM, Gargallo-Puyuelo, C, Ramos, CR, Arranz, MDM, Rivas, C, Capón, JG, Garcia, LA, Casbas, AG, San Jose, FB, Gonzalez, S, Lucia, M, Elorza, A, Sepulcre, MFG, Fernández-Salazar, L, Mínguez, A, Quiñones, M, Taxonera, C, Barreiro-de Acosta, M, Diaz, AP, Flores, EI, Cano, MP, Sese, E, Casals, DB, Bas-Cutrina, F, Glaría, EB, Moreno, AZG, Poceiro, JC, Lopez, LR, Moral, ED, Chaparro, M, Gisbert, J. Safety of biologic and small molecule therapies in IBD patients with previous cancer: risk of recurrence or new neoplasia. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.897. PMID:. IF:8.700(Q1/1D).
01/01/2026
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
de Célix, CR, Ricart, E, Martín-Arranz, MD, de Francisco, R, García-Alonso, FJ, Mesonero, F, Gomollón, F, de Castro, L, Ramos, L, García-López, S, Arias, L, Mañosa, M, Iglesias, E, Calvet, X, Bolufer, CS, Casanova, MJ, Pérez-Calle, JL, Giordano, A, Sierra-Ausín, M, Vera, I, Navarro-Llavat, M, Lorente, R, Piqueras, M, Rivero, M, Guardiola, J, Esteve, M, Coronel, AF, Rodríguez-Lago, I, Ponferrada-Díaz, A, Ber, Y, Tardillo, C, Márquez, L, Carpio, D, Taxonera, C, Bermejo, F, Busquets, D, Camps, B, Gutiérrez, A, García-Sepulcre, MF, Barreiro-de Acosta, M, Marín-Jiménez, I, Huguet, JM, Fernández-Salazar, LI, Jaó, J, Rodríguez-Gutiérrez, C, Martinez-Flores, C, Bujanda, L, Lucendo, AJ, Sesé, E, Andrés, PR, Ginard, D, Vega, P, Riera, J, Pajares, R, Van Domselaar, M, Almela, P, Pérez, TM, Muñoz-Villafranca, C, Varela, P, Argüelles-Arias, F, Nos, P, Alcaín, G, Hernández, L, Fernández, H, Muñoz, F, Gilabert, P, Navas-López, VM, de la Piscina, PR, Sánchez, LB, Gil, JL, Valldosera, G, Muñoz, RA, Frago, S, Domènech, E, Chaparro, M, Gisbert, JP. Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; 63(1)DOI:10.1111/apt.70312. PMID:40778752. IF:6.700(Q1/1D).
01/01/2026
Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn's disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group
Marquès-Camí, M, Vergés, L, Gonzalez, AE, Huguet, JM, Mateos, AMC, Caravaca, C, Molina, IGD, Suárez, C, Carballo-Folgoso, L, Vivo, MG, Cuadro, CP, Vicente, GT, Martin, MDCL, Ramos, CR, Jimenez, BV, Clotet, AF, Sandoval, CT, Torres, VM, Intriago, AC, Brunet, E, Martín, J, Marin, CAT, Medina, LT, Lozano, OM, Mínguez, A, Velázquez, LM, Sard, MC, Zabana, Y. Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn's disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.468. PMID:. IF:8.700(Q1/1D).
01/01/2026
Clinical and biological factors as predictors of mucosal healing in moderate ulcerative colitis treated with steroids
Ciria, MM, Guardia, JL, Piñero, GS, Sard, MC, Arranz, EM, Zabana, Y, Llavat, MN, Teller, M, Planella, EG, Casals, DB, Miquel, DM, Juan-Ramón, P, Casbas, AG, Ferrer, AV, Viso, LAM, Paz, GB, Alonso, FJG, Tirado, MR, Chaparro, M, Menéndez, SR, Ochoa, OM, Rodríguez-Lago,, Acosta, MBD, Rodríguez-Fortúnez, P, Moral, ED. Clinical and biological factors as predictors of mucosal healing in moderate ulcerative colitis treated with steroids. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.463. PMID:. IF:8.700(Q1/1D).
01/01/2026
Feasibility and safety of endoscopic submucosal dissection In inflammatory bowel disease (ESDEUR-IBD): an European retrospective study
García, MJ, Fraile, M, Katinios, G, Gubbiotti, A, Argyriou, K, Neri, B, Gonzalez, AE, Partida, IG, Gavric, A, Loly, JP, Parga, MLD, Fousekis, F, Quintana, LC, Suchanek, S, Caron, B, Guardia, JL, Terán, A, Abalos, JG, Poortmans, PJ, Hernández, LA, García, AL, Santos, DC, Pallares, PD, Elorza, A, Lopez, LR, Bednarska, O, Savarino, E, Manolakis, A, Mancone, R, Albéniz, E, de Frutos, D, Vieujen, S, Jesús, ARD, Skamnelos, A, Schaefer, M, Ribas, AM, Truyens, M, Romero, DG, López, RH, Tirado, MR. Feasibility and safety of endoscopic submucosal dissection In inflammatory bowel disease (ESDEUR-IBD): an European retrospective study. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1281. PMID:. IF:8.700(Q1/1D).
01/01/2026
Prevalence and Determinants of Anal and Oral Human Papillomavirus Infection in Men with Inflammatory Bowel Disease: Interim Results from the PAPIMALE Study
Giordano, A, Szafranska, J, Abalos, JG, Muñoza, CG, Vila, CG, Bertoletti, F, Gomez, ER, Planella, EG. Prevalence and Determinants of Anal and Oral Human Papillomavirus Infection in Men with Inflammatory Bowel Disease: Interim Results from the PAPIMALE Study. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1512. PMID:. IF:8.700(Q1/1D).
01/01/2026
SHORT-TERM HUMAN ALBUMIN THERAPY IMPROVES SERUM SODIUM CONCENTRATION AND REDUCES MORTALITY IN PATIENTS WITH CIRRHOSIS AND DILUTIONAL HYPONATREMIA
Juanola, A, Moreta, M, Sole, C, Pérez-Guasch, M, Ginès, JG, Soria, A, Cuyas, B, Martin-Llahi, M, Ma, A, Pompili, E, Amorós, M, Cruceta, A, Diestro, S, Domenech, G, Rios, J, Sánchez, J, Fabrellas, N, Graupera, I, Pose, E, Gines, P. SHORT-TERM HUMAN ALBUMIN THERAPY IMPROVES SERUM SODIUM CONCENTRATION AND REDUCES MORTALITY IN PATIENTS WITH CIRRHOSIS AND DILUTIONAL HYPONATREMIA. HEPATOLOGY. 2026; 83(1)DOI:. PMID:. IF:15.800(Q1/1D).
01/01/2026
Clinical outcomes in the implementation of peroral endoscopic myotomy (POEM): Results from the Spanish multicenter registry
Estremera-Arevalo, F, Bravo-Meléndez, S, Hijos-Mallada, G, Guarner-Argente, C, Murzi, M, Rodriguez-Santiago, E, de Tejada, AH, Uchima-Koecklin, H, Miranda-Garcia, P, Barquero-Declara, D, Riesco-López, JM, De Maria-Pallarés, P, Fernández-Esparrach, MG, Sánchez-Yagüe, A, Aresté-Anduaga, I, Gonzalez-Gete, G, Sanchez-Vegazof, CT, Penas-Garcia, B, Parejo-Carbonell, S, Martinez-Sánchez, A, Rojo, E, Mata-Bilbao, A, Araujo, IK, Montori, S, Gómez, M, Albeniz, E. Clinical outcomes in the implementation of peroral endoscopic myotomy (POEM): Results from the Spanish multicenter registry. Gastroenterologia y Hepatologia. 2026; 49(1)DOI:10.1016/j.gastrohep.2025.502527. PMID:40769466. IF:1.900(Q3/7D).
01/01/2026
Impact on peripheral catheter failure with the use of an extension set with integrated needleless connector compared with a straight hub: a prospective quasi-experimental study
Piriz-Marabajan, M, Rombauts, A, Roch-Villaverde, N, Cortes-Palacios, AP, Fernandez-Piqueras, E, Serrano-Condal, S, Taltavull-Menendez, M, Grillo, S, Simonetti, AF, Duch, P, Pomar-Solchaga, V, Escolà-Vergé, L, Lopez-Contreras, J. Impact on peripheral catheter failure with the use of an extension set with integrated needleless connector compared with a straight hub: a prospective quasi-experimental study. JOURNAL OF HOSPITAL INFECTION. 2026; 167DOI:10.1016/j.jhin.2025.09.009. PMID:41075840. IF:3.100(Q1/3D).
01/01/2026
Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry
Fernández-Lozano, D, Domínguez-Alvaro, M, Narváez, J, Garrido-Puñal, N, De Miguel, E, Estrada-Alarcon, P, Hernández-Rodríguez, I, Silva-Diaz, M, Belzunegui, JM, Moriano, C, Martín, JS, Calvo, I, Aldasoro, V, Abasolo, L, Loricera, J, Moya-Alvarado, P, García-Villanueva, MJ, Sánchez-Alonso, F, Castañeda, S, Hernández, JL, Blanco, R. Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry. RHEUMATOLOGY. 2026; 65(1)DOI:10.1093/rheumatology/keaf689. PMID:41452742. IF:4.400(Q1/1D).
01/01/2026
Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I
Ramos, D, Francesqui, J, Bollo, E, Villar, A, Florez, P, Balcells, E, Castaño, G, Pinillos-Robles, EJ, Godoy-Mayoral, R, Lopez-Muñiz, B, Soler-Sampere, MJ, Castillo, D, Rafecas-Codern, A, Mariscal-Aguilar, P, Portillo, K, Gomez-Carrera, L, Bonilla, G, Millan-Billi, P, Hernández-González, F, Sellarés, J. Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I. RESPIRATORY MEDICINE. 2026; 251DOI:10.1016/j.rmed.2025.108591. PMID:41418888. IF:3.100(Q2/4D).
01/01/2026
A New Horizon for an Old Disease: Modern Strategies for Approaching Chronic Cough
Domingo, C, Crespo-Lessmann, A, McGarvey, L. A New Horizon for an Old Disease: Modern Strategies for Approaching Chronic Cough. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(1)DOI:10.1016/j.arbres.2025.07.020. PMID:40887323. IF:9.200(Q1/1D).
01/01/2026
Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD
Casanova, C, Gonzalez-Dávila, E, De Torres, JP, Cabrera, C, Cosio, BG, O'Donnel, DE, Martínez-Gonzalez, C, Solanes, I, Fuster, A, Gotera, C, Marin, A, Amado, C, Iscar, M, Marin, JM, Neder, JA, Feu, N, Soriano, JB, López-Campos, JL, Divo, M, Peces-Barba, G, Celli, BR. Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(1)DOI:10.1016/j.arbres.2025.05.004. PMID:40447521. IF:9.200(Q1/1D).
01/01/2026
Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease
Viglino, J, Perea, L, Garcia-Nuñez, M, Rodrigo-Troyano, A, Torrego, A, Domínguez-Alvarez, M, Villar, J, Carrizosa, X, Quero, S, Gabaldon, T, Willis, JR, Saus, E, Gea, J, Santos, S, Camps, P, Agusti, A, Monso, E, Sibila, O, Faner, R. Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease. EBioMedicine. 2026; 123DOI:10.1016/j.ebiom.2025.106099. PMID:41483682. IF:10.800(Q1/1D).
01/01/2026
The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization
Domingo, P, Stapleton, JT. The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization. AIDS. 2026; 40(1)DOI:10.1097/QAD.0000000000004369. PMID:41489321. IF:3.100(Q2/4D).